IntegriChain was a proud sponsor at this year’s Life Sciences Pricing & Contracting USA Summit by Informa May 18 – 20, 2026 at the Philadelphia Marriott Downtown.

• Date: Wednesday, May 20, 2026 | 11:40 AM
• Session: Why Are Manufacturers at an Intersection with 340B — What's Next?
• Speaker: Clay Willis, Partner, Advisory Services

The 340B landscape is shifting faster than ever and manufacturers are caught in the middle. With fewer options to address program growth and misuse, the pressure to act strategically has never been greater. The rebate model remains constrained, contract pharmacy policies continue to evolve, and claim collection practices are drawing increased scrutiny from covered entities.

In this session, Clay Willis cut through the complexities and highlighted the most critical developments shaping the 340B environment today. Attendees walked away with a clearer picture of where things stand and a forward-looking view of more modernized, transparent approaches that can help manufacturers pursue long-term stability and predictability in their 340B strategy.